01Available sources
Starting point
The NCI's MyPART program presents the difficulty of studying rare cancers as a reason to bring patients, families and researchers together.
Sources for this section
- Why MyPART Focuses on Rare Cancer ResearchNational Cancer Institute / NIH
- NCI · Rare cancersNational Cancer Institute / NIH
02Under scientific review
What to investigate
How can relevant evidence be developed for each subtype, preserving context and limitations when available knowledge is limited?
Sources for this section
- Why MyPART Focuses on Rare Cancer ResearchNational Cancer Institute / NIH
LIMITATIONS AND CONTEXT
The scope of this reading
- This edition does not include a complete survey of treatments, studies or gaps for each rare tumor. The existence of the question does not imply that no therapies exist.
- A systematic review of supporting and opposing evidence has not yet been completed; the initial source selection is not exhaustive.
ORIGINAL READING
References and sources
- Why MyPART Focuses on Rare Cancer ResearchNational Cancer Institute / NIHSource publication: 2019-02-27
- NCI · Rare cancersNational Cancer Institute / NIH
- National Cancer Institute